|
Status |
Public on Sep 21, 2011 |
Title |
UPN23 |
Sample type |
genomic |
|
|
Source name |
UPN23
|
Organism |
Homo sapiens |
Characteristics |
age: 52 aml type: de novo AML 2 year overall survival: y 2 year progression free survival: n complete remission (cr): y npm1 status: Mut
|
Treatment protocol |
EZ methylation kit
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Ficoll separated fresh AML cells from diagnostic bone marrow samples were collected. DNA was extracted with the Dneasy kit(Qiagen)
|
Label |
biotin
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation27 Beadchip using standard Illumina protocol.
|
Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting.
|
Data processing |
The beta values are formatted for use with BeadStudio software v3.2 and Genesis (TU Graz), meaning that -0.5 equals no methylation and +0.5 full methylation on a linear scale. Samples are mean normalized using Genesis.
|
|
|
Submission date |
Sep 20, 2011 |
Last update date |
Sep 21, 2011 |
Contact name |
Stefan Deneberg |
Phone |
+46858580000
|
Organization name |
Karolinska Institutet
|
Department |
Internal medicine/Huddinge
|
Lab |
Hematology
|
Street address |
M54
|
City |
Stockholm |
ZIP/Postal code |
14186 |
Country |
Sweden |
|
|
Platform ID |
GPL8490 |
Series (2) |
GSE32251 |
Prognostic DNA Methylation Patterns in Cytogenetically Normal Acute Myeloid Leukemia are predefined by Stem Cell Chromatin Marks [methylation] |
GSE32252 |
Prognostic DNA Methylation Patterns in CN-AML; a genome wide methylation and gene expression study |
|